IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV) (NCT04262141) | Clinical Trial Compass
Active — Not RecruitingPhase 2
IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV)
United States4 participantsStarted 2020-10-02
Plain-language summary
The purpose of this study is to assess the hematologic effects of IMG-7289 therapy in ET and PV patients who require platelet, White Blood Cell (WBC) or Red Blood Cell (RBC) control, and have failed at least one standard therapy.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Age ≥ 18 years.
. Diagnosis of Essential Thrombocythemia or Polycythemia Vera per World Health Organization (WHO) diagnostic criteria for myeloproliferative neoplasms (Arber et al., 2016).
. Patients that have failed at least one standard therapy (failure is the equivalent of inadequate response or intolerance).
. Platelet count \>400 x 10\^9/L pre-dose Day 1for patients with essential thrombocytopenia.
. Platelet count \>150 x 10\^9/L pre-dose Day 1 for patients with polycythemia vera.
. Peripheral blast count \< 10% pre-dose Day 1.
. Absolute neutrophil count (ANC) ≥ 0.5 x 10\^9/L pre-dose Day 1.
. Fibrosis score ≤ grade 2, as per a slightly modified version (Arber et al., 2016) of the European Consensus Criteria for Grading Myelofibrosis, (Thiele et al., 2005).
Exclusion criteria
. Eastern Cooperative Oncology Group (ECOG) questionnaire score of 3 or greater.
. Currently pregnant, planning on being pregnant in the following 6 months or currently breastfeeding.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.